Alimera Sciences Inc
ALIMDelisted Sep 16, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267602
Alimera Sciences Inc was delisted on Sep 16, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 52 institutions reported holding it in 13F filings for Q2 2024, worth $257.9M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Alimera Sciences Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Alimera Sciences Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Caligan Partners LP | 10% Owner | 0Indirect | Sep 18, 2024 | 0 |
| Johnson David Edward | 10% Owner | 0Indirect | Sep 18, 2024 | 0 |
| DeMont Ross D | Director | – | Sep 18, 2024 | 0 |
| Eiswirth Richard S Jr | President and CEO | 0 | Sep 18, 2024 | 0 |
| Holland David | Chief Marketing Officer & SVP | 0 | Sep 18, 2024 | 0 |
| Pizzo Peter J. III | Director | 0 | Sep 18, 2024 | 0 |
| Ashman Philip | President of Int'l Operations | 0 | Sep 18, 2024 | 0 |
| Maltz Elliot | Chief Financial Officer | – | Sep 18, 2024 | 0 |
| Kaseta Michael | Director | – | Sep 18, 2024 | 0 |
| Wood Todd Michael | President of U.S. Operations | – | Sep 18, 2024 | 0 |
| Snisarenko John | Director | 0 | Sep 18, 2024 | 0 |
| Parsons Erin | Director | – | Sep 18, 2024 | 0 |
| Werner Jason M. | Chief Operating Officer | 225,000 | Sep 18, 2024 | 0 |
| Pax Margaret | Director | – | Sep 18, 2024 | 0 |
| Venkataraman Balaji | 10% Owner | 0Indirect | Sep 16, 2024 | 0 |
| Velan Capital Investment Management LP | 10% Owner | 0Indirect | Sep 16, 2024 | 0 |
| Morgan Adam | Director, 10% Owner | 0Indirect | Sep 16, 2024 | 0 |
| Velan Capital Holdings LLC | 10% Owner | 0Indirect | Sep 16, 2024 | 0 |
| Velan Capital Management LLC | 10% Owner | 0Indirect | Sep 16, 2024 | 0 |
| Velan Capital Master Fund LP | 10% Owner | 0Indirect | Sep 16, 2024 | 0 |
| Velan Capital SPV I LLC | 10% Owner | 0Indirect | Sep 16, 2024 | 0 |
| Skibsted Russell | Chief Financial Officer & SVP | 75,500 | Nov 28, 2023 | 0 |
| Myers C. Daniel | Other: Chairman Emeritus | – | Aug 3, 2023 | 0 |
| Palo Alto Investors LP | 10% Owner | 0Indirect | Mar 28, 2023 | 0 |
| Sawhney Roger | Director | – | Mar 1, 2023 | 0 |
| Largent James R | Director | 13,000 | Jan 6, 2023 | 0 |
| Halak Brian K | Director | 327 | Jan 6, 2023 | 0 |
| Kong Garheng | Director | – | Jan 6, 2023 | 0 |
| Jones John Philip | Chief Financial Officer | 32,185 | Nov 2, 2022 | 0 |
| Morgan Stanley | 10% Owner | 557,551Indirect | Feb 10, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2021 (view filing) | Nov 3 | 1 day | Holland DavidChief Marketing Officer & SVP | PPurchase | +5.00K | $4.08 | +$20.4K | +19.1%31.1K after | |
| Nov 4, 2021 (view filing) | Nov 3 | 1 day | Eiswirth Richard S JrPresident and CEO | PPurchase | +28.0K | $4.45 | +$124.6K | +46.3%88.5K after | |
| Nov 4, 2021 (view filing) | Nov 3 | 1 day | Jones John PhilipChief Financial Officer | PPurchase | +5.00K | $4.08 | +$20.4K | +25.0%25.0K after | |
| Nov 4, 2021 (view filing) | Nov 3 | 1 day | Largent James RDirector | PPurchase | +10.0K | $4.31 | +$43.1K | +333.3%13.0K after | |
| Nov 8, 2021 (view filing) | Nov 4-5 | 4 days | Eiswirth Richard S JrPresident and CEO | PPurchase | +11.5K | $4.54 | +$52.2K | +13.0%100.0K after | 2 lots |
| Dec 6, 2021 (view filing) | Dec 2 | 4 days | Eiswirth Richard S JrPresident and CEO | PPurchase | +5.00K | $4.89 | +$24.4K | +5.0%105.0K after | |
| Dec 7, 2021 (view filing) | Dec 3 | 4 days | Eiswirth Richard S JrPresident and CEO | PPurchase | +5.00K | $4.80 | +$24.0K | +4.8%110.0K after | |
| Dec 16, 2021 (view filing) | Dec 15 | 1 day | Eiswirth Richard S JrPresident and CEO | PPurchase | +484 | $4.50 | +$2.18K | +0.4%110.5K after | |
| Feb 10, 2022 (view filing) | Feb 8 | 2 days | Morgan Stanley10% Owner | SSale | −250.0K | $4.55 | −$1.14M | −31.0%557.6K after | |
| Mar 28, 2023 (view filing) | Mar 24 | 4 days | Palo Alto Investors LP10% Owner | SSale | −200.9K | $1.56 | −$313.4K | −100.0%0 after | |
| Mar 28, 2023 (view filing) | Mar 24 | 4 days | Palo Alto Investors LP10% Owner | SSale | −601.5K | $1.56 | −$936.0K | –0 after | Derivative |
| May 19, 2023 (view filing)5:17 PM ET | May 17 | 2 days | Morgan AdamDirector, 10% Owner | PPurchase | +1.40M | $1.70 | +$2.38M | +543.9%1.66M after | |
| May 19, 2023 (view filing)5:17 PM ET | May 17 | 2 days | Morgan AdamDirector, 10% Owner | PPurchaseSeries B Convertible Preferred Stock | +15.1K | – | – | –7.00K after | Derivative2 lots |
| Sep 15, 2023 (view filing)4:05 PM ET | Sep 14 | 1 day | Caligan Partners LP and 1 other10% Owner | SSaleCommon Stock, par value 0.01 per share (Common Stock) | −579.0K | $3.39 | −$1.96M | −3.4%16.3M after | |
| Sep 15, 2023 (view filing)4:05 PM ET | Sep 14 | 1 day | Caligan Partners LP and 1 other10% Owner | PPurchase | +579.0K | $3.39 | +$1.96M | +3.6%16.8M after |